Smith Nephew Snats Stock Today

SNN Stock  USD 28.41  0.13  0.46%   

Performance

3 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 9

 
High
 
Low
Low
Smith Nephew is selling at 28.41 as of the 12th of October 2024; that is 0.46 percent decrease since the beginning of the trading day. The stock's open price was 28.54. Smith Nephew has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Smith Nephew SNATS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 12th of September 2024 and ending today, the 12th of October 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
16th of November 1999
Category
Healthcare
Classification
Health Care
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 435.99 M outstanding shares of which 3.52 M shares are at this time shorted by investors with about 5.03 days to cover. More on Smith Nephew SNATS

Moving together with Smith Stock

  0.61CI Cigna CorpPairCorr
  0.75LH LaboratoryPairCorr
  0.64MD Mednax IncPairCorr

Moving against Smith Stock

  0.83DRIO DarioHealth CorpPairCorr
  0.76OM Outset MedicalPairCorr
  0.69DXCM DexCom IncPairCorr
  0.67VREX Varex Imaging Corp Fiscal Year End 12th of November 2024 PairCorr
  0.64VTAK Catheter PrecisionPairCorr
  0.56DH Definitive HealthcarePairCorr

Smith Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Chief Executive OfficerDeepak Nath
Thematic Ideas
(View all Themes)
Old NameSanne Group plc
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Bucharest BET-NG, Bucharest Total Return, Bucharest Plus Index, Bucharest BET-XT Index, Medical Equipment, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.0250.0263
Notably Down
Slightly volatile
Asset Turnover0.940.5556
Way Up
Slightly volatile
Gross Profit Margin0.580.667
Fairly Down
Slightly volatile
Net Debt2.9 B2.8 B
Sufficiently Up
Slightly volatile
Total Current Liabilities2.4 B2.3 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total2.6 B2.5 B
Sufficiently Up
Slightly volatile
Total Assets10.5 B10 B
Sufficiently Up
Slightly volatile
Total Current Assets4.2 BB
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities529.2 M608 M
Fairly Down
Very volatile
Debt Levels
Smith Nephew can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Smith Nephew's financial leverage. It provides some insight into what part of Smith Nephew's total assets is financed by creditors.
Liquidity
Smith Nephew SNATS has 3.08 B in debt with debt to equity (D/E) ratio of 0.54, which is OK given its current industry classification. Smith Nephew SNATS has a current ratio of 1.74, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Smith to invest in growth at high rates of return.

Depreciation

283.55 Million
Smith Nephew SNATS (SNN) is traded on New York Stock Exchange in USA. It is located in Building 5, Watford, United Kingdom, WD18 8YE and employs 18,000 people. Smith Nephew is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 12.44 B. Smith Nephew SNATS runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 435.99 M outstanding shares of which 3.52 M shares are at this time shorted by investors with about 5.03 days to cover. Smith Nephew SNATS has about 516 M in cash with 608 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.18.
Check Smith Nephew Probability Of Bankruptcy
Ownership Allocation
Smith Nephew SNATS shows a total of 435.99 Million outstanding shares. About 91.2 % of Smith Nephew outstanding shares are held by general public with 0.02 (%) owned by insiders and only 8.78 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Smith Ownership Details

Smith Stock Institutional Holders

InstituionRecorded OnShares
Clark Estates Inc2024-06-30
750 K
Balyasny Asset Management Llc2024-06-30
650.1 K
Sio Capital Management, Llc2024-06-30
579.6 K
Hsbc Holdings Plc2024-06-30
548.7 K
Jane Street Group Llc2024-06-30
547.4 K
Dimensional Fund Advisors, Inc.2024-06-30
524.6 K
Wells Fargo & Co2024-06-30
512.6 K
Envestnet Asset Management Inc2024-06-30
485.5 K
Fmr Inc2024-06-30
448.2 K
Fiduciary Management, Inc. Of Milwaukee2024-06-30
4.4 M
Barrow Hanley Mewhinney & Strauss Llc2024-06-30
4.2 M
View Smith Nephew Diagnostics

Smith Nephew Historical Income Statement

At this time, Smith Nephew's Reconciled Depreciation is very stable compared to the past year. View More Fundamentals

Smith Stock Against Markets

Smith Nephew Corporate Directors

Bob WhiteNon-Executive Independent DirectorProfile
Erik EngstromNon-Executive Independent DirectorProfile
Marc OwenNon-Executive Independent DirectorProfile
AnneFrancoise NesmesChief Financial Officer, Executive DirectorProfile
When determining whether Smith Nephew SNATS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Smith Nephew's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Smith Nephew Snats Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Smith Nephew Snats Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Smith Nephew SNATS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Smith Nephew. If investors know Smith will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Smith Nephew listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.244
Dividend Share
0.375
Earnings Share
0.7
Revenue Per Share
2.5904
Quarterly Revenue Growth
0.034
The market value of Smith Nephew SNATS is measured differently than its book value, which is the value of Smith that is recorded on the company's balance sheet. Investors also form their own opinion of Smith Nephew's value that differs from its market value or its book value, called intrinsic value, which is Smith Nephew's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Smith Nephew's market value can be influenced by many factors that don't directly affect Smith Nephew's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Smith Nephew's value and its price as these two are different measures arrived at by different means. Investors typically determine if Smith Nephew is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Smith Nephew's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.